Fingerpaint Group Acquires The MYND Group
Deal is expected to boost company’s market access capabilities.
Fingerpaint Group, an integrated collective of healthcare companies that provide commercialization solutions that span the entire product life cycle, is strengthening its market access offering with the acquisition of The MYND Group, a full-service strategic market access marketing company that works in the pharma and biologics spaces.
The company joins Fingerpaint Group's specialty services offerings that include medical and scientific communications, market access, and naming and branding capabilities.
"The MYND Group brings extensive market access strategy, research, and launch experience across multiple categories, including in the growing vaccine category," notes Bill McEllen, Fingerpaint Group’s global president. "This is our second market access acquisition in the last 3 years and is part of our continued commitment to evolving our market access capabilities to match the expectations and needs of the industry."
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
